Press OA - Search Results

1

Gene polymorphisms of epidermal growth factor receptor and its downstream effector, interleukin-8, predict oxaliplatin efficacy in patients with advanced colorectal cancer.

Zhang W, Stoehlmacher J, Park DJ, Yang D, Borchard E, Gil J, Tsao-Wei DD, Yun J, Gordon M, Press OA, Rhodes K, Groshen S, Lenz HJ. Zhang W, et al. Among authors: press oa. Clin Colorectal Cancer. 2005 Jul;5(2):124-31. doi: 10.3816/ccc.2005.n.025. Clin Colorectal Cancer. 2005. PMID: 16098254

2

Epidermal growth factor receptor gene polymorphisms predict pelvic recurrence in patients with rectal cancer treated with chemoradiation.

Zhang W, Park DJ, Lu B, Yang DY, Gordon M, Groshen S, Yun J, Press OA, Vallböhmer D, Rhodes K, Lenz HJ. Zhang W, et al. Among authors: press oa. Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):600-5. Clin Cancer Res. 2005. PMID: 15701846

3

Molecular determinants of cetuximab efficacy.

Vallböhmer D, Zhang W, Gordon M, Yang DY, Yun J, Press OA, Rhodes KE, Sherrod AE, Iqbal S, Danenberg KD, Groshen S, Lenz HJ. Vallböhmer D, et al. Among authors: press oa. J Clin Oncol. 2005 May 20;23(15):3536-44. doi: 10.1200/JCO.2005.09.100. J Clin Oncol. 2005. PMID: 15908664

4

Genomic profiling associated with recurrence in patients with rectal cancer treated with chemoradiation.

Gordon MA, Gil J, Lu B, Zhang W, Yang D, Yun J, Schneider S, Groshen S, Iqbal S, Press OA, Rhodes K, Lenz HJ. Gordon MA, et al. Among authors: press oa. Pharmacogenomics. 2006 Jan;7(1):67-88. doi: 10.2217/14622416.7.1.67. Pharmacogenomics. 2006. PMID: 16354126

5

Cyclin D1 and epidermal growth factor polymorphisms associated with survival in patients with advanced colorectal cancer treated with Cetuximab.

Zhang W, Gordon M, Press OA, Rhodes K, Vallböhmer D, Yang DY, Park D, Fazzone W, Schultheis A, Sherrod AE, Iqbal S, Groshen S, Lenz HJ. Zhang W, et al. Among authors: press oa. Pharmacogenet Genomics. 2006 Jul;16(7):475-83. doi: 10.1097/01.fpc.0000220562.67595.a5. Pharmacogenet Genomics. 2006. PMID: 16788380 Clinical Trial.

6

Association of methylenetetrahydrofolate reductase gene polymorphisms and sex-specific survival in patients with metastatic colon cancer.

Zhang W, Press OA, Haiman CA, Yang DY, Gordon MA, Fazzone W, El-Khoueiry A, Iqbal S, Sherrod AE, Lurje G, Lenz HJ. Zhang W, et al. Among authors: press oa. J Clin Oncol. 2007 Aug 20;25(24):3726-31. doi: 10.1200/JCO.2007.11.4710. J Clin Oncol. 2007. PMID: 17704422

7

Gender-related survival differences associated with EGFR polymorphisms in metastatic colon cancer.

Press OA, Zhang W, Gordon MA, Yang D, Lurje G, Iqbal S, El-Khoueiry A, Lenz HJ. Press OA, et al. Cancer Res. 2008 Apr 15;68(8):3037-42. doi: 10.1158/0008-5472.CAN-07-2718. Cancer Res. 2008. PMID: 18413774

8

Press OA, Zhang W, Gordon MA, Yang D, Haiman CA, Azuma M, Iqbal S, Lenz HJ. Press OA, et al. Pharmacogenomics J. 2011 Oct;11(5):375-82. doi: 10.1038/tpj.2010.45. Epub 2010 Jun 15. Pharmacogenomics J. 2011. PMID: 20548329 Free PMC article.

9

ABCB1, SLCO1B1 and UGT1A1 gene polymorphisms are associated with toxicity in metastatic colorectal cancer patients treated with first-line irinotecan.

Rhodes KE, Zhang W, Yang D, Press OA, Gordon M, Vallböhmer D, Schultheis AM, Lurje G, Ladner RD, Fazzone W, Iqbal S, Lenz HJ. Rhodes KE, et al. Among authors: press oa. Drug Metab Lett. 2007 Jan;1(1):23-30. doi: 10.2174/187231207779814328. Drug Metab Lett. 2007. PMID: 19356014 Clinical Trial.

10

Characterization of HER2 status by fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC).

Press OA, Guzman R, Cervantes M, Santiago A, Press MF. Press OA, et al. Methods Mol Biol. 2014;1180:181-207. doi: 10.1007/978-1-4939-1050-2_10. Methods Mol Biol. 2014. PMID: 25015148

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page